Dyphenhidramine Effect on Prevention of Sevoflurane Induced Post Anesthesia Agitation in Pediatric
Specified Sedative, Hypnotic
About this trial
This is an interventional prevention trial for Specified Sedative focused on measuring Diphenhydramine, emergence agitation, pediatric anesthesia, PAEDS, Withdrawal
Eligibility Criteria
Inclusion Criteria:
ASA I or 2
- no cardiovascular, respiratory or neurologic congenital anomalies
- no allergic reactions, or any contraindication to drugs used in this trial ever documented
Exclusion Criteria:
- congenital anomalies recognized/diagnosed during trial procedures
- hemmorhage > 15% EBV
- shock or other major anesthesia or surgical complications during trial procedures (hipoxia, atelectasis, unintended disconection of ETT or IV line)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
diphenhydramine
control
Subject sedated with sevoflurane, and given bilateral extraoral infraorbital block with 0,125% bupivacaine. Subject injected 0,5mg/kg diphenhydramine intravenously, 15 minutes prior to discontinuation of sevoflurane. If subject develop agitation, 0,1 mg/kg ketamine is administered
Subject sedated with sevoflurane, and given bilateral extraoral infraorbital block with 0,125% bupivacaine. Subject injected 0,5cc/kg normal saline intravenously, 15 minutes prior to discontinuation of sevoflurane. If subject develop agitation, 0,1 mg/kg ketamine is administered